Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis

被引:0
作者
Tang, S
Ho, YW
Leung, CY
Lai, KN
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[2] United Christian Hosp, Dept Med & Genet, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Tissue Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
focal segmental glomerulosclerosis; mycophenolate mofetil; steroid-resistance; remission;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report our experience in using mycophenolate mofetil (MMF) for the treatment of steroid-resistant focal segmental glomerulosclerosis (FSGS) in two patients. Patient 1, who was treated on disease presentation, responded well with sustained complete remission. Patient 2, who had unsuccessful steroid treatment 4 yrs before and was re-treated with MMF, showed transient retardation in renal disease progression but eventually progressed to end-stage renal failure. Our observation illustrates that MMF could be useful in treating steroid-resistant FSGS if administered at an early phase of the disease, well before histologic damage becomes irreversible. Its efficacy requires validation in randomized, controlled trials. The current armamentaria for the treatment of this condition are also discussed.
引用
收藏
页码:429 / 432
页数:4
相关论文
共 14 条
[1]  
Allison AC, 1996, CLIN TRANSPLANT, V10, P77
[2]   Mycophenolate mofetil: implications for the treatment of glomerular disease [J].
Badid, C ;
Desmouliere, A ;
Laville, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (09) :1752-1756
[3]   Pathogenesis of focal glomerulosclerosis [J].
Bolton, WK ;
Abdel-Rahman, E .
NEPHRON, 2001, 88 (01) :6-13
[4]   Management of focal segmental glomerulosclerosis: Evidence-based recommendations [J].
Burgess, E .
KIDNEY INTERNATIONAL, 1999, 55 :S26-S32
[5]   Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis [J].
Chan, TM ;
Li, FK ;
Tang, CSO ;
Wong, RWS ;
Fang, GX ;
Ji, YL ;
Lau, CS ;
Wong, AKM ;
Tong, MKL ;
Chan, KW ;
Lai, KN .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) :1156-1162
[6]   Predicting renal survival in primary focal glomerulosclerosis from the time of presentation [J].
Chitalia, VC ;
Wells, JE ;
Robson, RA ;
Searle, M ;
Lynn, KL .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2236-2242
[7]   Mycophenolate mofetil treatment for primary glomerular diseases [J].
Choi, MJ ;
Eustace, JA ;
Gimenez, LF ;
Atta, MG ;
Scheel, PJ ;
Sothinathan, R ;
Briggs, WA .
KIDNEY INTERNATIONAL, 2002, 61 (03) :1098-1114
[8]   Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome [J].
Day, CJ ;
Cockwell, P ;
Lipkin, GW ;
Savage, COS ;
Howie, AJ ;
Adu, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (11) :2011-2013
[9]  
GRINYO J, 1995, LANCET, V345, P1321
[10]   Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade [J].
Montané, B ;
Abitbol, C ;
Chandar, J ;
Strauss, J ;
Zilleruelo, G .
PEDIATRIC NEPHROLOGY, 2003, 18 (08) :772-777